Outcome of ADPKD With Octreotide LAR

NCT06193616 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Autosomal Dominant Polycystic Kidney

Interventions

DRUG: Octreotide

Sponsor

Mario Negri Institute for Pharmacological Research